CR

Christophe Ricard

Europe, Geneve, Switzerland, Geneva

Description

Christophe Ricard CEO of OM Pharma

Investor Profile

Christophe Ricard has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Christophe Ricard frequently co-invest with?

AMR Action Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Turenne Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Christophe Ricard?

Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
Series BDec 12, 2023
Amount Raised: $26,996,237
Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
SeedJan 12, 2012